All Stories

  1. Is It Stem Cell or Magic Potion? The Case of Autologous Fat Injection
  2. Gutflix ‘How to Develop Guidelines’ Series
  3. Clinical impact of double-faecal immunochemical testing following implementation into standard triage and investigation of primary care referrals in patients with lower gastrointestinal symptoms
  4. Risk factors and clinical consequences of interval cancers arising within faecal immunochemical testing-based colorectal cancer screening programme
  5. The Increased Early Onset Colorectal Cancer in South East Scotland Is Indicative of a Wider UK Problem
  6. Editorial April 2025: The protocolisation of evidence synthesis: The good, the bad and the ugly
  7. Editorial March 2025: Getting the guidelines we need
  8. What Constitutes a High‐Quality Guideline: Exploring Consumers' Views
  9. Look east for perianal fistula surgery
  10. Hearing what isn't said
  11. Diagnostic Performance of Faecal Immunochemical Testing (FIT) in Patients with Lynch Syndrome Scheduled for Colonoscopic Surveillance
  12. Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways
  13. Rainfall causing diverticulitis: A parable of data mining
  14. Quality of clinical guidelines: It matters as it impacts patient care
  15. The power of p
  16. Patients’ frailty and co-morbidities do not affect short-term mortality following emergency colorectal cancer surgery
  17. Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
  18. Oncological and clinical outcomes after conventional right hemicolectomy
  19. Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing
  20. European Society of Coloproctology guidance on the use of mesh in the pelvis in colorectal surgery
  21. Short‐term outcomes of a COVID‐adapted triage pathway for colorectal cancer detection
  22. Nurse-led telephone outreach for a COVID-adapted suspected colorectal cancer pathway
  23. Implementation of a risk mitigating COVID-adapted colorectal cancer pathway
  24. Posterior Tibial Nerve Stimulation for Faecal Incontinence
  25. Development of a customised data management system for a COVID-19-adapted colorectal cancer pathway
  26. The COVID‐19 pandemic: considerations for resuming normal colorectal services
  27. Healthcare apps: why have they not really taken off
  28. Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic
  29. Contemporary surgical practice in the management of anal fistula: results from an international survey
  30. Home parenteral nutrition and employment in patients with intestinal failure: Factors associated with return to employment
  31. The Renew® anal insert for passive faecal incontinence: a retrospective audit of our use of a novel device
  32. A review of the effect of faecal incontinence and constipation on sexual function
  33. Long-term outcome of laparoscopic rectopexy for full-thickness rectal prolapse
  34. Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review
  35. Mapping the current flow in sacral nerve stimulation using computational modelling.
  36. Regeneration of the oesophageal muscle layer from oesophagus acellular matrix scaffold using adipose-derived stem cells
  37. Assessment and management of patients with intestinal failure: a multidisciplinary approach
  38. Standardising assessment and documentation of pouchoscopy
  39. A meta-analysis comparing open anterior component separation with posterior component separation and transversus abdominis release in the repair of midline ventral hernias
  40. Hypoxia Enhances Differentiation of Adipose Tissue-Derived Stem Cells toward the Smooth Muscle Phenotype
  41. Combined Laparoscopic and Perineal Approach to Omental Interposition Repair of Complex Rectovaginal Fistula
  42. Current practice of continence advisors in managing faecal incontinence in the United Kingdom: results of an online survey
  43. The prevalence of chronic peri‐pouch sepsis in patients treated for antibiotic‐dependent or refractory primary idiopathic pouchitis
  44. Complex abdominal wall reconstruction in the setting of active infection and contamination: a systematic review of hernia and fistula recurrence rates
  45. Long-term outcome of sacral neuromodulation for chronic refractory constipation
  46. Major Complex Abdominal Wall Repair in Contaminated Fields with Use of a Non‐cross‐linked Biologic Mesh: A Dual‐Institutional Experience
  47. The role of the defaecating pouchogram in the assessment of evacuation difficulty after restorative proctocolectomy and pouch–anal anastomosis
  48. European Society of Coloproctology consensus on the surgical management of intestinal failure in adults
  49. Neuromodulation
  50. Sacral nerve stimulation for faecal incontinence and constipation: a European consensus statement
  51. Response to: consensus on ventral rectopexy: report of a panel of experts
  52. Outcome of Sacral Nerve Stimulation for Fecal Incontinence at 5 Years
  53. Patient Responses to Different Neuromodulatory Treatments
  54. Perianal injectable bulking agents as treatment for faecal incontinence in adults
  55. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in patients with previous adenomas and/or genetic disposition
  56. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing recurrence and metachronous colorectal carcinomas in patients previously treated for colorectal cancer
  57. The Problematic Sacral Neuromodulation
  58. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in general population
  59. Sacral Nerve Stimulation for Fecal Incontinence
  60. Percutaneous tibial nerve stimulation for slow transit constipation: a pilot study
  61. Medium-Term Outcome of Sacral Nerve Modulation for Constipation
  62. Postoperative Issues of Sacral Nerve Stimulation for Fecal Incontinence and Constipation: A Systematic Literature Review and Treatment Guideline
  63. Long-term outcome of the use of botulinum toxin injection for functional anal pain
  64. Sacral Nerve Stimulation
  65. Gracilis muscle transposition for complex fistula and persistent nonhealing sinus in perianal Crohnʼs disease
  66. Faecal incontinence following radiotherapy for prostate cancer: A systematic review
  67. Suboptimal outcome following sacral nerve stimulation for faecal incontinence
  68. Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy
  69. Sacral Nerve Stimulation for Constipation: Suboptimal Outcome and Adverse Events
  70. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease
  71. Perianal injectable bulking agents as treatment for faecal incontinence in adults
  72. Predictors of the outcome of percutaneous nerve evaluation for faecal incontinence
  73. The role of pouch compliance measurement in the management of pouch dysfunction
  74. Retention Test in Sacral Nerve Stimulation for Fecal Incontinence
  75. Physiological, psychological and behavioural characteristics of men and women with faecal incontinence
  76. Perianal injectable bulking agents as treatment for faecal incontinence
  77. W1210 Clinical Outcome Measures of Response to Pharmacological Treatment in Perianal Crohn's Disease
  78. Open Hemorrhoidectomy
  79. Does the St. Mark's Incontinence Score Reflect Patients' Perceptions? A Review of 390 Patients
  80. Response to Smart et al.
  81. St. Mark's Incontinence Score
  82. Pilot study of two new injectable bulking agents for the treatment of faecal incontinence
  83. Long‐term results of perianal silicone injection for faecal incontinence
  84. Injectable Bulking Agents